Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bebbington David is active.

Publication


Featured researches published by Bebbington David.


Archive | 2011

inibidores de enzima conversora de interleucina-1beta, bem como composição farmacêutica.

Batchelor Mark J; Bebbington David; Bemis Guy W; Fridman Wolf Herman; Gillespie Roger J; Golec Julian M C; Gu Yong; Lauffer David J; Livingston David J; Matharu Saroop S; Mullican Michael D; Murcko Mark A; Murdoch Robert; Nyce Philip L; Robidoux Andrea L C; Su Michael; Wannamaker M Woods; Wilson Keith P; Zelle Robert E


Archive | 2010

Inhibitors of interleukin-1beta converting enzyme, pharmaceutical composition containing thereof and process for their preparation

Batchelor Mark J; Bebbington David; Bemis Guy W; Fridman Wolf Herman; Gillespie Roger J; Golec Julian M C; Gu Yong; Lauffer David J; Livingston David J; Matharu Saroop S; Mullican Michael D; Murcko Mark A; Murdoch Robert; Nyce Philip L; Robidoux Andrea L C; Su Michael; Wannamaker M Woods; Wilson Keith P; Zelle Robert E


Archive | 2010

Pyrazolforbindelser samt anvendelse derav for fremstilling av medikamenter til behandling av lidelser assosiert med Aurora-2-, GSK-3- eller Src-aktivitet

Golec Julian M C; Charrier Jean-Damien; Knegtel Ronald; Bebbington David; Miller Andrew


Archive | 2009

N-Acylamino compounds functioning as interleukin-1{beta} converting enzyme inhibitors, process of their preparation a pharmaceutical compositions comprising thereof

Batchelor Mark J; Bebbington David; Bemis Guy W; Fridman Wolf Herman; Gillespie Roger J; Golec Julian M C; Gu Yong; Lauffer David J; Livingston David J; Matharu Saroop S; Mullican Michael D; Murcko Mark A; Murdoch Robert; Nyce Philip L; Robidoux Andrea L C; Su Michael; Wannamaker M Woods; Wilson Keith P; Zelle Robert E


Archive | 2009

AZOLYLAMINOAZINE ALS INHIBITOREN VON PROTEINKINASEN

Bebbington David; Binch Hayley; Charrier Jean-Damien; Everitt Simon; Golec Julian M; Kay David; Knegtel Ronald; Miller Andrew; Pierard Francoise


Archive | 2008

Carbamatcaspaseinhibitorer og anvendelse deraf

Knegtel Ronald; Bebbington David; Charrier Jean-Damien; Kay David; Golec Julian; Mortimore Michael; Studley John


Archive | 2008

Pyrazole compound useful as protein kinase inhibitor

Bebbington David; Charrier Jean-Damien; Golec Julian; Miller Andrew; Knegtel Ronald


Archive | 2008

Carbamat caspase inhibitoren und deren verwendung

Bebbington David; Charrier Jean-Damien; Kay David; Knegtel Ronald; Golec Julian; Mortimore Michael; Studley John


Archive | 2007

ßPYRAZOLVERBINDUNGEN, DIE SICH ALS PROTEINKINASEINHIBITOREN EIGNENß

Bebbington David; Charrier Jean-Damien; Golec Julian; Green Jeremy; Kay David; Knegtel Ronald; Miller Andrew; Tomlison Ronald; Li Pan


Archive | 2007

N-Acylamino compounds as inhibitors of enzyme converting 1{beta}-interleukin, process of their preparation and pharmaceutical compositions containing thereof

Batchelor Mark J; Bebbington David; Bemis Guy W; Fridman Wolf Herman; Gillespie Roger J; Golec Julian M C; Gu Yong; Lauffer David J; Livingston David J; Matharu Saroop S; Mullican Michael D; Murcko Mark A; Murdoch Robert; Nyce Philip L; Robidoux Andrea L C; Su Michael; Wannamaker M Woods; Wilson Keith P; Zelle Robert E

Collaboration


Dive into the Bebbington David's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kay David

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Su Michael

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge